SALEM INVESTMENT COUNSELORS INC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 61 filers reported holding GALECTIN THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SALEM INVESTMENT COUNSELORS INC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$378
-5.5%
1670.0%0.00%
Q1 2024$400
+43.9%
1670.0%0.00%
Q4 2023$278
-13.4%
1670.0%0.00%
Q3 2023$321
+33.2%
1670.0%0.00%
Q2 2023$241
-31.3%
1670.0%0.00%
Q1 2023$351
+85.7%
1670.0%0.00%
Q4 2022$1891670.0%0.00%
Q3 2022$01670.0%0.00%
Q2 2022$01670.0%0.00%
Q1 2022$01670.0%0.00%
Q4 2021$0
-100.0%
1670.0%0.00%
Q3 2021$1,0000.0%1670.0%0.00%
Q2 2021$1,0001670.0%0.00%
Q1 2021$01670.0%0.00%
Q4 2020$01670.0%0.00%
Q3 2020$0
-100.0%
1670.0%0.00%
Q2 2020$1,0001670.0%0.00%
Q1 2020$01670.0%0.00%
Q4 2019$0
-100.0%
1670.0%0.00%
Q3 2019$1,0000.0%1670.0%0.00%
Q2 2019$1,0000.0%1670.0%0.00%
Q2 2018$1,0000.0%1670.0%0.00%
Q4 2017$1,0001670.0%0.00%
Q2 2017$01670.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q1 2024
NameSharesValueWeighting ↓
Benchmark Capital Advisors 221,700$1,051,0000.83%
EAM Global Investors LLC 227,063$1,076,0000.56%
EAM Investors, LLC 319,187$1,513,0000.25%
COURAGE CAPITAL MANAGEMENT LLC 30,000$142,0000.11%
Cutter & CO Brokerage, Inc. 53,600$254,0000.10%
SABBY MANAGEMENT, LLC 286,800$1,360,0000.08%
D.A. DAVIDSON & CO. 731,300$3,466,0000.07%
Tibra Equities Europe Ltd 63,414$301,0000.05%
Advisor Group, Inc. 556,377$2,637,0000.04%
Laurel Wealth Advisors, Inc. 21,400$101,0000.03%
View complete list of GALECTIN THERAPEUTICS INC shareholders